Cny Medical & Allergy is categorized under Allergists in Rome, NY and active since 2008.
Cny Medical & Allergy was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Allergists business, which does work in the B2C market, and is classified as a Allergists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Pamela Allessi, Office Manager at the company’s single location by writing to 1617 North James St # 500, Rome, New York NY 13440 or by phoning (315) 339-3182. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cny Medical & Allergy |
| Contact Person: | Pamela Allessi, Office Manager |
| Address: | 1617 North James St # 500, Rome, New York 13440 |
| Phone Number: | (315) 339-3182 |
| Website Address: | cnymedicine-allergy.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Allergists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Cny Medical & Allergy was started in 2008 to provide professional Allergists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Pamela Allessi, Office Manager for inquiries that concern Cny Medical & Allergy by calling the company number (315) 339-3182, as your correspondence is most welcome. Additionally, the physical location of the single location of Cny Medical & Allergy can be found at the coordinates 43.23046,-75.44324 as well as the street address 1617 North James St # 500 in Rome, New York 13440.
For its online presence, you may visit Cny Medical & Allergy’s website at cnymedicine-allergy.com and engage with its social media outlets through on Twitter and on Facebook.